SCHEMBL13079587

SCHEMBL13079587

O=Nc1cccc2c(=O)n(Cc3ccc4c(c3)OCCO4)ccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 5/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
CYP2D6 P10635 1/20 0.41
MAPT P10636 6/20 0.41
TP53 P04637 3/20 0.41
NR5A1 Q13285 4/20 0.41
RORA P35398 1/20 0.41
POLB P06746 1/20 0.41
PDE5A O76074 1/20 0.40
HPGD P15428 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
HSD17B10 Q99714 2/20 0.39
ESR1 P03372 1/20 0.39
TSHR P16473 1/20 0.39
PTPN7 P35236 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CMA1 P23946 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1893427 0.85 PARP1 (0.47) ALDH1A1KDM4EKMT2ALMNAMEN1
SCHEMBL12668491 0.84 MAPT (0.47) ALDH1A1KDM4EKMT2ALMNAMEN1
SCHEMBL1895931 0.84 ALDH1A1 (0.46) ALDH1A1KDM4EKMT2ALMNAMEN1
SCHEMBL5137598 0.81 MAPT (0.51) ALDH1A1KDM4EKMT2ALMNAMEN1
SCHEMBL1896463 0.80 MAPT (0.48) ALDH1A1KDM4EKMT2ALMNAMEN1
SCHEMBL13774307 0.78 DHPS (0.54) ALDH1A1KDM4EKMT2ALMNAMEN1
SCHEMBL12675462 0.72 MAPT (0.45) ALDH1A1KDM4EMAPTTP53NR5A1
SCHEMBL3739328 0.72 P2RX7 (0.52) ALDH1A1KDM4ELMNAMAPTTP53
SCHEMBL1892742 0.71 MAPT (0.45) ALDH1A1KDM4ELMNAMAPTTP53
SCHEMBL4991283 0.71 P2RX7 (0.57) ALDH1A1KDM4ENR5A1RORAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 ALDH1A1 3640/4885KDM4E 4128/4885KMT2A 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.